Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineered™ monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors
Goel, S., Bauer, R. J., Desai, K., Bulgaru, A., Iqbal, T., Strachan, B.-K., Kim, G., Kaubisch, A., Vanhove, G. F., Goldberg, G., Mani, S.
Published in Annals of oncology (01.10.2007)
Published in Annals of oncology (01.10.2007)
Get full text
Journal Article
Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors
Goel, S., Bulgaru, A., Hochster, H., Wadler, S., Zamboni, W., Egorin, M., Ivy, P., Leibes, L., Muggia, F., Lockwood, G., Harvey, E., Renshaw, G., Mani, S.
Published in Annals of oncology (01.11.2003)
Published in Annals of oncology (01.11.2003)
Get full text
Journal Article
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineered super(TM) monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors
Goel, S, Bauer, R J, Desai, K, Bulgaru, A, Iqbal, T, Strachan, B-K, Kim, G, Kaubisch, A, Vanhove, G F, Goldberg, G, Mani, S
Published in Annals of oncology (01.10.2007)
Get full text
Published in Annals of oncology (01.10.2007)
Journal Article
A Safety Study of a Mixed-backbone Oligonucleotide (GEM231) Targeting the Type I Regulatory Subunit α of Protein Kinase A Using a Continuous Infusion Schedule in Patients with Refractory Solid Tumors
Goel, Sanjay, Desai, Kavita, Bulgaru, Anca, Fields, Abbie, Goldberg, Gary, Agrawal, Sudhir, Martin, Russell, Grindel, Michael, Mani, Sridhar
Published in Clinical cancer research (15.09.2003)
Get full text
Published in Clinical cancer research (15.09.2003)
Journal Article
A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies
Friedman, D. T., Goel, S., Desai, K., Verdier-Pinard, D., Kaubisch, A., Bulgaru, A., Camacho, F., Goldberg, G., Mani, S.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
A phase I clinical trial with weekly irinotecan (IRI) and capecitabine (CAP) in patients with advanced gastrointestinal and other solid malignancies
Friedman, D. T., Goel, S., Desai, K., Verdier-Pinard, D., Kaubisch, A., Bulgaru, A., Camacho, F., Goldberg, G., Mani, S.
Published in Journal of clinical oncology (15.07.2004)
Published in Journal of clinical oncology (15.07.2004)
Get full text
Journal Article
Phase I and pharmacokinetic study of a subcutaneously administered human-engineered monoclonal antibody ING-1 in patients with advanced adenocarcinomas
Kiner-Strachan, B., Goel, S., Vanhove, G., Bauer, R. J., Verdier-Pinard, D., Karri, S., Desai, K., Bulgaru, A., Macapinlac, M., Mani, S.
Published in Journal of clinical oncology (01.06.2005)
Published in Journal of clinical oncology (01.06.2005)
Get full text
Journal Article
Pharmacokinetic and safety study of subcutaneously administered weekly ING-1, a human engineere monoclonal antibody targeting human EpCAM, in patients with advanced solid tumors
Goel, S, Bauer, R J, Desai, K, Bulgaru, A, Iqbal, T, Strachan, B-K, Kim, G, Kaubisch, A, Vanhove, G F, Goldberg, G, Mani, S
Published in Annals of oncology (01.10.2007)
Get full text
Published in Annals of oncology (01.10.2007)
Journal Article